Parthenolide Modulates the NF-κB–Mediated Inflammatory Responses in Experimental Atherosclerosis

Abstract

NF-kappaB inhibition by PTN retards atherosclerotic lesions in apoE mice, by reducing lesion size and changing plaque composition. This natural compound could represent a novel therapeutic approach to inflammation during vascular damage.